Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Press Releases

12345678910
World Vape Day 2026: One Switch – Everyone Wins
BRUSSELS, May 30, 2026 (GLOBE NEWSWIRE) -- Today, vapers, former smokers, and harm reduction advocates mark World Vape Day 2026. The theme this year is One Switch – Everyone Wins. It is not a slogan. It is what the data shows.
By World Vapers’ Alliance · Via GlobeNewswire · May 30, 2026
Xtreme HD IPTV Unveils Enhanced Digital Platform to Improve Customer Experience and Service Accessibility
Company introduces a faster, mobile-optimized website designed to simplify access to IPTV services and customer resources.
Via ACCESS Newswire · May 30, 2026
Momcozy Launches Plus Baby Wipes Built for Every “Messy Milestone”: 99% Purified Water, 8″ × 8″, Independently Certified by Intertek
Designed around the “Bring On The Mess” philosophy, the new wipes are larger than most leading brands by sheet dimensions, formulated with 99% purified water and coconut extract, and independently tested for safety by Intertek
By Momcozy · Via GlobeNewswire · May 30, 2026
NYC Done-For-You Content Marketing For Small Business Visibility Announced
MediaRise is now offering "done-for-you" multichannel content marketing campaigns for small and medium-sized businesses in New York City and Westchester, distributing branded content across more than 300 platforms to support long-term organic visibility.
Asprofin Bank Explores Up to USD 12 Billion Sovereign Data Center Programme Across Three Strategic UAE Sites
DUBAI, UAE / ACCESS Newswire / May 30, 2026 / As global demand for artificial intelligence infrastructure accelerates at unprecedented speed, Asprofin Bank Corporation has announced it is evaluating a large-scale sovereign data center programme across three strategic sites in the United Arab Emirates.
Via ACCESS Newswire · May 30, 2026
Advanced Body Contouring in Los Angeles: VASER Liposuction Compared to Traditional Lipo
Liposuction continues to rank among the most popular cosmetic procedures in the world, helping patients remove stubborn fat deposits that often resist diet and exercise. However, many patients are now discovering that not all liposuction procedures are the same.
Via AB Newswire · May 30, 2026
Taurus Management Highlights Growing Demand for Pre IPO Investment Opportunities
Taurus Management has reported increasing investor interest in the rapidly evolving pre IPO sector as technological innovation continues to reshape global markets and accelerate company growth.
Via GlobePRwire · May 30, 2026
Chicago, IL Author Publishes Thriller Novel
Ambition Can Build An Empire.
Via PR Leap · May 30, 2026
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to accelerate the next generation of oncology breakthroughs leveraging its foundational model. The PRECISION Challenge aims to unlock breakthroughs in oncology at scale by providing access to data, funding, and expertise to multidisciplinary teams around the world who seek to make bold advances in cancer treatment and improve patient outcomes.
By Tempus AI, Inc. · Via Business Wire · May 30, 2026
Tummy Tuck vs Liposuction: How Patients Choose the Right Body Contouring Procedure
One of the most common questions patients ask during a body contouring consultation is whether they should choose a tummy tuck, liposuction, or a combination of both procedures.
Via AB Newswire · May 30, 2026
Café Water Purification System: Bluewater Station 1 For Perfect Coffee Launched
Bluewater launches Café Station 1, a water purification and mineralisation system for cafés. The system removes 99.7% of contaminants, re-mineralises water, and allows real-time TDS adjustment via mobile app.
Kaplan Fox Encourages Investors of AeroVironment, Inc. (NASDAQ: AVAV) to Contact the Firm Before Lead Plaintiff Deadline on July 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · May 30, 2026
Lake George, CO Author Publishes Memoir
A Century Of Wisdom Meets A Journey Of Love
Via PR Leap · May 30, 2026
Kaplan Fox Encourages Investors of AeroVironment, Inc. (NASDAQ: AVAV) to Contact the Firm Before Lead Plaintiff Deadline on July 27, 2026
NEW YORK, NY - May 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) on behalf of investors that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026 (the “Class Period”).
Via TheNewswire.com · May 30, 2026
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer (mCRC) co-sponsored by Summit and Akeso, featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab. The data were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
By Summit Therapeutics · Via Business Wire · May 30, 2026
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate test identifies which men with metastatic prostate cancer benefit from adding the chemotherapy docetaxel to standard hormonal therapy (ADT plus enzalutamide), known as triplet therapy, and who can safely avoid it, providing the first Level 1B 1 evidence for a genomic test guiding this decision. Complementary data presented at the meeting also reinforce Decipher Prostate's clinical utility in high-risk localized disease.
By Veracyte, Inc. · Via Business Wire · May 30, 2026
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3.
By Incyte · Via Business Wire · May 30, 2026
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Preview, an application providing rapid, clinically significant insights that close the gap between the time of order and delivery of insights. Representing a significant paradigm shift in precision oncology workflows, Tempus Preview offers preliminary results in the critical window between when a diagnostic test is ordered and when final sequencing results are delivered by surfacing key mutation predictions within approximately 24 hours of tissue receipt.
By Tempus AI, Inc. · Via Business Wire · May 30, 2026
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled Phase 3 trial of varegacestat in patients with progressing desmoid tumors. The data are being presented today in an oral abstract session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Immunome submitted an NDA for varegacestat to the FDA in April 2026.
By Immunome, Inc. · Via Business Wire · May 30, 2026
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
Pfizer Inc. (NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in men with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). These results will be presented today in a late-breaking oral presentation (Abstract LBA5007) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The New England Journal of Medicine.
By Pfizer Inc. · Via Business Wire · May 30, 2026
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of Liver (EASL) Congress in Barcelona, Spain, demonstrating the first clinical evidence of epigenetic silencing in hepatitis B virus (HBV).
By Tune Therapeutics · Via Business Wire · May 30, 2026
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
Houston, Texas and Tuebingen, Germany, May 30, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced updated Phase 1 data for its IMA203CD8 PRAME TCR T-cell therapy in gynecologic cancers and synovial sarcoma at the Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL, USA. One-time infusion of IMA203CD8 demonstrated meaningful clinical activity across different tumor types as well as manageable tolerability. The broad expression of PRAME in more than 50 cancers further supports the continued development of IMA203CD8 in multiple PRAME-positive solid tumors.
By https://immatics.com/ · Via GlobeNewswire · May 30, 2026
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival data from the IGNYTE clinical trial of RP1 plus nivolumab in patients with anti-PD-1 failed melanoma during an oral session at the 2026 American Society of Clinical Oncology annual meeting.
By Replimune, Inc. · Via GlobeNewswire · May 30, 2026
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will hold trial-in-progress poster presentations on the Phase 1/2a study of its lead targeted alpha radiotherapy candidate MP0712 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. ASCO takes place May 29-June 2 in Chicago, and SNMMI May 30-June 2 in Los Angeles.
By Molecular Partners · Via GlobeNewswire · May 30, 2026
GODADDY ALERT: GoDaddy Inc. (NYSE: GDDY) Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · May 30, 2026
GODADDY ALERT: GoDaddy Inc. (NYSE: GDDY) Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - May 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY).
Via TheNewswire.com · May 30, 2026
Ultimate Guide to Software Stability: Top Infrastructure Solutions for Modern QA Teams
In modern Agile and DevOps environments, deployment cycles are continuous. Engineering teams push updates multiple times per day, making early-stage validation critical for maintaining system stability.
Via BusinesNews Wire · May 30, 2026
Simply Good Foods Company (NASDAQ: SMPL) Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · May 30, 2026
Simply Good Foods Company (NASDAQ: SMPL) Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
NEW YORK, NY - May 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Simply Good Foods Company (“Simply Good” or the “Company”) (NASDAQ: SMPL).
Via TheNewswire.com · May 30, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IMMP
NEW YORK, May 30, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · May 30, 2026
How to Build a Quiz for Shopify That Matches Customers With Products
Most online shoppers leave without buying – not because they don’t want something, but because they can’t figure out what’s right for them. Too many options, too little guidance. A well-built quiz for Shopify [follow] changes that dynamic entirely. Instead of leaving customers to browse and second-guess, it walks them through a few targeted questions and hands them exactly what they need. The result? Faster decisions, higher conversions, and a shopping experience that actually feels personal.
Via BusinesNews Wire · May 30, 2026
How Training Programs Benefit Both Kids and Adults in Building Discipline and Confidence
People treat it like punishment or rigid structure. Something forced onto children. Something adults lose interest in once life becomes busy enough. I’ve never seen it that way. Real discipline is usually quieter. Repetition. Patience. Showing up when motivation disappears for a while.
Via BusinesNews Wire · May 30, 2026
Kaplan Fox Encourages Investors of Zoetis Inc. (NYSE: ZTS) to Contact the Firm Before Lead Plaintiff Deadline on July 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · May 30, 2026
SMX and the Age of Parity: Recycled Plastic Is No Longer a Sustainability Choice-It's an Economic Imperative
NEW YORK CITY, NY / ACCESS Newswire / May 30, 2026 / Recycled plastic is no longer just a sustainability gesture. For years, it was treated as a responsible choice, a brand signal, or a way for companies to show progress toward environmental goals.
Via ACCESS Newswire · May 30, 2026
Kaplan Fox Encourages Investors of Zoetis Inc. (NYSE: ZTS) to Contact the Firm Before Lead Plaintiff Deadline on July 27, 2026
NEW YORK, NY - May 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) on behalf of investors that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026 (the “Class Period”).
Via TheNewswire.com · May 30, 2026
Bollywood Meets Hollywood: Skully Brandon Draws Attention Following Role in Vande Bharat via USA
The entertainment world is witnessing a growing crossover between Bollywood and Hollywood, and actor-influencer Skully Brandon is quickly becoming one of the names generating buzz on both sides of the industry. Following his appearance in the Bollywood feature film Vande Bharat via USA, Brandon is now attracting attention from film studios and production companies exploring international collaborations.
Via BusinesNews Wire · May 30, 2026
Why KW Hammocks Hammock Chairs Are Becoming The Go-To Choice For Stylish Indoor & Outdoor Relaxation
There was a time when relaxation furniture meant a recliner in the corner or a lawn chair on the patio. But neither option was aesthetically pleasing, nor did it provide comfortable seating.
Via BusinesNews Wire · May 30, 2026
American Airlines Credit Union: A Trusted Financial Partner for Aviation Professionals
In today’s fast-paced financial world, finding a reliable institution that understands the unique needs of its members is essential. American Airlines Credit Union has built a strong reputation as a member-focused financial cooperative that serves individuals connected to the aviation industry. With a history spanning decades, competitive financial products, and a commitment to customer service, the credit union continues to be a preferred choice for thousands of members.
Via GlobePRwire · May 30, 2026
Best ADU Floor Plans for Small California Lots: Design Principles and Examples
Plan, permit, design and build your ADU in California with ADUscale. Get cost estimates, financing options and a step-by-step roadmap from concept to construction.
Via GlobePRwire · May 30, 2026
Fluent Trends Releases New Guide on Styling Accent Pillows and Area Rugs
Fluent Trends has released a new styling guide that explains how to coordinate accent pillows and area rugs using texture, color distribution, and proper sizing. The resource offers practical frameworks for homeowners seeking clearer interior design direction.
12B SPORTS Named Main Sponsor of VR46 Racing Team for the 2026 MotoGP Season
By 12B SPORTS · Via GlobeNewswire · May 30, 2026
How to Prepare for Your First Trade Show Event
Walking into the trade show for the very first time is an important event for any business. This is because there will be plenty of buzz in the air, and lots of opportunities for meeting leads and peers within your industry.
Via BusinesNews Wire · May 30, 2026
Melbourne, FL Author Publishes Health Care Discussion
Exploring the Ancient Wisdom of Traditional Chinese Medicine
Via PR Leap · May 30, 2026
Central City, KY Author Publishes Children's Book
Teaching Important Lessons Through a Thrilling Forest Adventure
Via PR Leap · May 30, 2026
The Law Office of Richard M. Kenny Secures Seven-Figure Settlement for Collision Victim
The Law Office of Richard M. Kenny is pleased to announce a significant, seven-figure settlement for one of our clients, a North Carolina man who suffered a traumatic brain injury after a devastating intersection crash in Manhattan on Thanksgiving Eve.
Via PR Leap · May 30, 2026
Antaun C.L. Barnett Focuses on Frictionless Sales Infrastructure in Insurance
May 30, 2026 -- Antaun C.L. Barnett, MBA of North Carolina and New York, is helping reshape insurance distribution through shared services, sales enablement systems, and operational infrastructure designed to reduce friction for agents and organizations.
Via 24-7 Press Release · May 30, 2026
Beat the PECO Bill: AC Saving Tips for Philly Homeowners
May 30, 2026 -- Summer in Philadelphia brings notorious row home humidity, soaring temperatures, and inevitably, expensive PECO energy bills. As a Philadelphia homeowner, keeping your house cool without draining your wallet requires strategy.
Via 24-7 Press Release · May 30, 2026
Dion Emami Says Workforce Development Is the Utility Industry's Biggest Challenge
May 30, 2026 -- Orange County and Los Angeles–based utility executive Dianoush "Dion" Emami is calling attention to the growing workforce gap in the utility sector and the urgent need to mentor the next generation of engineers, project managers, and field leaders.
Via 24-7 Press Release · May 30, 2026
Luvme Hair Shares Guide to Cool and Comfortable Summer Wig Wear
May 30, 2026 -- The beauty brand offers practical tips for choosing, wearing, and caring for wigs during warm-weather routines, summer travel, and everyday styling.
Via 24-7 Press Release · May 30, 2026
Douglas French Uncovers the True Causes of Financial Manias in Early Speculative Bubbles Increases in the Supply of Money 4th Expanded Edition
In a compelling and thought-provoking work, economist Douglas E. French challenges long-held beliefs about financial bubbles in his book Early Speculative Bubbles & Increases in the Supply of Money: 4th Expanded Edition . This groundbreaking analysis revisits some of the most famous speculative events in history, offering a bold conclusion: these crises were not driven by irrational behavior alone, but by significant expansions in the money supply fueled by government intervention.
Via Get News · May 30, 2026